Progress in Molecular Biology and Translational Science

David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.

• 1. Targeting recently deorphainzed GPR83 for the treatment of infection, stress, drug addictionLakshmi A. Devi2. Arrestin Structure-FunctionVsevolod V. Gurevich3. Arrestins in the Cardiovascular SystemAnastasios Lymperopoulos4. Analysis of biased agonismFrederick Ehlert5. Roles of different subtypes of estrogen receptors in cancer cell metabolismHaifei Shi6. Arrrestins in cell migration or Arrestins in inflammationKathryn Defea